Adhesins of Acinetobacter strains

One of the important factors contributing to the pathogenicity of bacteria is the presence of adhesins on cell surface, which facilitate colonisation in the macroorganism. The presence and type of adhesins occurring in four species of the genus Acinetobacter: A. baumannii (184), A. junii (59), A. lwoffii (65) and A. haemolyticus (22) was determined by haemagglutination test with a 3% suspension of fresh, tannic acid-treated of guinea pig, cow and human group O and AB erythrocytes, with or without the addition of one of sugar inhibitors (D-mannose, alpha-methylmannopyranoside, D-galactose-N-acetyl-D-glucosamine, L-fucose and D-ribose). In strains from all species, adhesines of the mannose-resistant (MR) type dominated. The mannose-sensitive (MS) type was present solely on the surface of one A. lwoffii strains. A. baumannii (36), A. junii (8), A. lwoffii (11) and A. haemolyticus (4) exhibited mannose-resistant hemagglutination in relation to fresh erythrocytes and that reaction was restrained by D-galactose, D-galactose and L-fucose (no other inhibitor used restrained it). The results achieved prove that cell adhesines other than those of MR type must be present on the cell surface. Additional adhesines occurred mainly in strains isolated from the respiratory and urinary tract infection simples, but were not found in isolates from blood cultures.     

鲍曼不动杆菌烈性噬菌体的分离与纯化

利用柱层析方法,纯化鲍曼不动杆菌（Acinetobacter baumannii）烈性噬菌体AB1。首先采用聚乙二醇6000沉淀方法,初步分离裂解液中的噬菌体,噬菌体纯度由6.1×1010 pfu/mg提高到37×1010 pfu/mg,噬菌体回收率为58.8%,蛋白质去除率为90.6%;噬菌体粗提样品经Sepharose 4B凝胶过滤层析柱进一步纯化,纯度提高到73×1010 pfu/mg,噬菌体回收率为95.7%,蛋白质去除率为48.1%;收集的噬菌体样品最后经DEAE-52阴离子交换层析柱处理,噬菌体纯度为40×1010 pfu/mg,回收率为50.8%,蛋白去除率15.6%。内毒素分析结果显示,Sepharose 4B凝胶过滤层析纯化的噬菌体样品中,内毒素含量为443.8 EU/mg,而DEAE-52阴离子交换层析纯化的噬菌体样品中,内毒素含量为544.4 EU/mg。实验结果显示,PEG沉淀方法与Sepharose 4B凝胶过滤方法能够有效地提高噬菌体纯度,而DEAE-52阴离子交换层析则不能提高噬菌体的纯度,也无法有效地去除样品中的内毒素。     

Polyphosphate production by strains of Acinetobacter

Of four strains of Acinetobacter isolated from a pilot plant exhibiting enhanced biological phosphate removal from sewage, two strains (RA3116 and RA3117) accumulated more than 10 times the amount of polyphosphate accumulated by the other two strains (RA3114 and RA3123). Variants isolated from RA3116 and RA3117 showed polyphosphate levels similar to RA3114 and RA3123. No correlation was found between the polyphosphate content of the strains and levels of several enzymes that have been implicated in polyphosphate formation.     

鲍曼不动杆菌遗传操作系统研究进展

鲍曼不动杆菌作为一种医院内感染的病原菌,因其易于引起各类感染且耐药性强而受到广泛关注。快速改造鲍曼不动杆菌基因组的工具可有效促进其耐药机制的研究。本文就近些年来适用于鲍曼不动杆菌的遗传操作方法进行了总结,包括各种外源基因转入方法(电转化、自然转化、接合转移)和基因改造技术(等位基因交换、DNA重组工程、转座突变),并对鲍曼不动杆菌的基因组编辑方法的改进作了初步展望。     

Uptake of acetate by Acinetobacter calcoaceticus

The uptake of acetate by intact nongrowing cells of Acinetobacter calcoaceticus was studied in dependence on the C-source (acetate, n-alcanes, yeast extract, succinate, L-malate) and the growth phase. Single kinetic parameters of acetate uptake were determined. The best acetate uptake was observed with cells cultivated with acetate as the only C-source. Bacteria in the early growth phase were found to transfer acetate twice as fast as cells of the late logarithmic growth phase. The uptake of acetate can be described by a biphasic saturation kinetics with 2 Km values: the Km value for the first phase being 1.10(-5) M, and for the second one, 1.8 .10(-4) M. The corresponding maximal uptake rates are 8 and 37 mM/min/mg dry weight, respectively. Alpha-ketoglutarate, fumarate, L-malate, and oxalacetate inhibit the initial uptake of acetate. Uranylacetate, inhibitors of the respiratory chain and proton conductors in part completely inhibit the uptake of acetate.     

Genome sequence of Acinetobacter baumannii MDR-TJ

Acinetobacter baumannii is a pathogenic species of bacteria, identified as an aerobic gram-negative bacterium, that is resistant to most antibiotics. In this study, the MDR-TJ strain was isolated at the Second Hospital of Tianjin Medical University, China, and was found to be resistant to penicillin, cephalosporins, aminoglycosides, quinolones, and also imipenem. The genome sequence of Acinetobacter baumannii strain MDR-TJ was determined by using a combination of 454 pyrosequencing and paired-end sequencing performed with the Roche Genome Sequencer FLX system to generate a scaffolded assembly.     

PCR genotyping of Acinetobacter hospital isolates

A total of 13 Acinetobacter baumannii-13TU isolates obtained from patients of the Perm regional clinical hospital during the period of 1 year, were genotyped in the polymerase chain reaction (PCR) with universal primers. Acinetobacter cultures could not be distinguished by phenotypic tests and antibiogram and were resistant to B-lactams and gentamicin. According to the results of amplification the obtained isolates could be subdivided into two groups (with 6 and 7 respectively). The detection of "epidemic" strains, including those capable of prolonged (for more than 5 months) persistence in hospital environment, may be indicative of the growing role of Acinetobacter as the causative agent in nosocomial infection.     

Growth of Acinetobacter calcoaceticus on Ethanol

A soil microorganism, identified as Acinetobacter calcoaceticus, was cultivated on ethanol as a sole source of carbon. This organism grew with a maximum specific growth rate of 0.7/h. The pH optimum for growth was between 6.5 and 7.5, and the temperature optimum was between 32 and 35 C. Ethanol metabolism by this organism was inducible by ethanol, and the presence of acetate led to the repression of ethanol dehydrogenase. At higher cell densities the cessation of growth on ethanol was accompanied by the accumulation of acetate or acetaldehyde, or both. These accumulations were attributed to a reduction in the magnesium or sulfur content of the medium and a lack of feedback inhibition by acetate of alcohol dehydrogenase.     

Concerning the sensitivity of Acinetobacter calcoaceticus

The strains of Acinetobacter calcoaceticus, var. anitratus (A. c. a.) were isolated in the nosocomial environment as an opportune pathogen. The therapy of choice may be determined after in vitro tests. Our results show following therapeutical possibilities: beta-lactam antibiotics--cephalosporins of IIIrd generation (cefotaxime), also combinations of antimicrobials have shown good results: amoxycillin or ticarcillin with clavulanic acid. Best synergistic effect was found in combination ticarcillin-amikacin.     

Phosphorylation of Acinetobacter isocitrate lyase.

During growth on succinate, Acinetobacter calcoaceticus contains two forms of the enzyme isocitrate dehydrogenase. Addition of acetate to a lag-phase culture grown on succinate causes a dramatic increase in activity of form II of isocitrate dehydrogenase and in isocitrate lyase. Form II of isocitrate dehydrogenase may be responsible for the partition of isocitrate between the TCA cycle and the glyoxylate by-pass. This report describes the phosphorylation of the enzyme isocitrate lyase from A. calcoaceticus. This phosphorylation may be a regulatory mechanism for the glyoxylate by-pass.     

鲍曼不动杆菌的耐药机制研究进展

鲍曼不动杆菌是临床常见感染菌,耐药性日益增强。其多重耐药性与可长期存活性将导致菌膜的形成,而这种可以抵抗抗菌素治疗的菌膜有着复杂的机构,在复杂结构中起到形成菌膜、维持菌膜稳定性的两个重要组成部分为胞外多糖(EPS)和菌膜相关性蛋白(the biofilm-associated protein,Bap),促使鲍曼不动杆菌躲避宿主免疫系统的攻击,因此针对鲍曼不动杆菌的治疗也愈发困难。     

鲍曼不动杆菌疫苗的研究进展

鲍曼不动杆菌为不动杆菌属中最常见的一种革兰阴性杆菌,同时也是医院获得性感染的主要致病菌之一。由于其广泛的耐药性,普通抗生素对其治疗效果已不明显。近年来,国内外学者尝试通过研制抗菌疫苗的手段来防治鲍曼不动杆菌感染,主要有灭活全菌体疫苗、外膜囊泡、重组蛋白亚单位疫苗、荚膜多糖候选疫苗、联合疫苗等。现就鲍曼不动杆菌疫苗的研究进展进行了综述。     

Acinetobacter pneumonia: a review

Acinetobacter species are becoming a major cause of nosocomial infections, including hospital-acquired and ventilator-associated pneumonia. Acinetobacter species have become increasingly resistant to antibiotics over the past several years and currently present a significant challenge in treating these infections. Physicians now rely on older agents, such as polymyxins (colistin), for treatment. This paper reviews the epidemiology, treatment, and prevention of this emerging pathogen.